LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.66 | 84.90 | 463 | 285 | 1.6204 | 1.6348 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 2.66 | 84.90 | 596 | 285 | 2.0858 | 2.0435 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.36 | 84.90 | 560 | 322 | 1.7360 | 1.6633 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 4.36 | 84.90 | 697 | 322 | 2.1608 | 1.9838 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.06 | 84.90 | 630 | 365 | 1.7239 | 1.5902 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.06 | 84.90 | 2 | 365 | 0.0055 | -0.8313 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 6.06 | 84.90 | 799 | 365 | 2.1863 | 1.8997 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.77 | 84.90 | 725 | 411 | 1.7630 | 1.5657 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.77 | 84.90 | 2 | 411 | 0.0049 | -0.8073 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.77 | 84.90 | 880 | 411 | 2.1399 | 1.7937 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.47 | 84.90 | 762 | 447 | 1.7031 | 1.4972 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.47 | 84.90 | 6 | 447 | 0.0134 | -0.6688 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 9.47 | 84.90 | 923 | 447 | 2.0629 | 1.7051 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.18 | 84.90 | 2 | 492 | 0.0041 | -0.7719 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.18 | 84.90 | 793 | 492 | 1.6106 | 1.4135 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.18 | 84.90 | 6 | 492 | 0.0122 | -0.6483 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 11.18 | 84.90 | 999 | 492 | 2.0290 | 1.6436 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | F13 |